| Irene Perillo, MD | |
|
601 Elmwood Ave, Box Med, Rochester, NY 14642-0001 | |
| (585) 275-4861 | |
| (585) 273-1058 |
| Full Name | Irene Perillo |
|---|---|
| Gender | Female |
| Speciality | Pulmonary Disease |
| Experience | 32 Years |
| Location | 601 Elmwood Ave, Rochester, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487685921 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Highland Hospital | Rochester, NY | Hospital |
| Strong Memorial Hospital | Rochester, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| County Of Monroe | 3072420959 | 7 |
| Highland Hospital Of Rochester | 5496641631 | 328 |
| Pulmonary Disease Clinical Group | 6608821657 | 62 |
News Archive
Prior Scientific's Z-Deck range is a high quality, height adjustable platform designed specifically for upright microscopes widely used in electrophysiology and neuroscience, including the Nikon FN1/Ni, the Olympus BX51WI / BX61WI, and the Zeiss Axio Examiner microscopes.
The Christian Science Monitor reports that the health overhaul is resting in the GOP's crosshairs. The ultimate defense to the repeal effort is the presidential veto pen. Even with a new majority in the House come January, Republicans concede that winning a repeal vote in the Democratic-controlled Senate is unlikely and the two-thirds needed to override a presidential veto, well out of reach.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that the U.S. Food and Drug Administration has approved the Company's Supplemental New Drug Application for FUSILEV Injection.
Insurers and patients are decrying the cost for the new drug, nearly $95,000 for a 12-week course of treatment, which is more expensive than Gilead's other hepatitis C drug, Sovaldi. But unlike some hepatitis C treatments, Harvoni can be taken without injections usually given to hepatitis C patients.
Innovative Therapies Inc. announced today the signing of a negative pressure wound therapy contract with the Mid-Atlantic Group Network of Shared Services, encompassing both rental and sales of ITI's proprietary NPWT technology.
› Verified 7 days ago
| Entity Name | University Of Rochester |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710226824 PECOS PAC ID: 5799699088 Enrollment ID: O20031201000019 |
News Archive
Prior Scientific's Z-Deck range is a high quality, height adjustable platform designed specifically for upright microscopes widely used in electrophysiology and neuroscience, including the Nikon FN1/Ni, the Olympus BX51WI / BX61WI, and the Zeiss Axio Examiner microscopes.
The Christian Science Monitor reports that the health overhaul is resting in the GOP's crosshairs. The ultimate defense to the repeal effort is the presidential veto pen. Even with a new majority in the House come January, Republicans concede that winning a repeal vote in the Democratic-controlled Senate is unlikely and the two-thirds needed to override a presidential veto, well out of reach.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that the U.S. Food and Drug Administration has approved the Company's Supplemental New Drug Application for FUSILEV Injection.
Insurers and patients are decrying the cost for the new drug, nearly $95,000 for a 12-week course of treatment, which is more expensive than Gilead's other hepatitis C drug, Sovaldi. But unlike some hepatitis C treatments, Harvoni can be taken without injections usually given to hepatitis C patients.
Innovative Therapies Inc. announced today the signing of a negative pressure wound therapy contract with the Mid-Atlantic Group Network of Shared Services, encompassing both rental and sales of ITI's proprietary NPWT technology.
› Verified 7 days ago
| Entity Name | Mary Imogene Bassett Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083664221 PECOS PAC ID: 3779488325 Enrollment ID: O20031205000553 |
News Archive
Prior Scientific's Z-Deck range is a high quality, height adjustable platform designed specifically for upright microscopes widely used in electrophysiology and neuroscience, including the Nikon FN1/Ni, the Olympus BX51WI / BX61WI, and the Zeiss Axio Examiner microscopes.
The Christian Science Monitor reports that the health overhaul is resting in the GOP's crosshairs. The ultimate defense to the repeal effort is the presidential veto pen. Even with a new majority in the House come January, Republicans concede that winning a repeal vote in the Democratic-controlled Senate is unlikely and the two-thirds needed to override a presidential veto, well out of reach.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that the U.S. Food and Drug Administration has approved the Company's Supplemental New Drug Application for FUSILEV Injection.
Insurers and patients are decrying the cost for the new drug, nearly $95,000 for a 12-week course of treatment, which is more expensive than Gilead's other hepatitis C drug, Sovaldi. But unlike some hepatitis C treatments, Harvoni can be taken without injections usually given to hepatitis C patients.
Innovative Therapies Inc. announced today the signing of a negative pressure wound therapy contract with the Mid-Atlantic Group Network of Shared Services, encompassing both rental and sales of ITI's proprietary NPWT technology.
› Verified 7 days ago
| Entity Name | Mary Imogene Bassett Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083664221 PECOS PAC ID: 3779488325 Enrollment ID: O20040120000834 |
News Archive
Prior Scientific's Z-Deck range is a high quality, height adjustable platform designed specifically for upright microscopes widely used in electrophysiology and neuroscience, including the Nikon FN1/Ni, the Olympus BX51WI / BX61WI, and the Zeiss Axio Examiner microscopes.
The Christian Science Monitor reports that the health overhaul is resting in the GOP's crosshairs. The ultimate defense to the repeal effort is the presidential veto pen. Even with a new majority in the House come January, Republicans concede that winning a repeal vote in the Democratic-controlled Senate is unlikely and the two-thirds needed to override a presidential veto, well out of reach.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that the U.S. Food and Drug Administration has approved the Company's Supplemental New Drug Application for FUSILEV Injection.
Insurers and patients are decrying the cost for the new drug, nearly $95,000 for a 12-week course of treatment, which is more expensive than Gilead's other hepatitis C drug, Sovaldi. But unlike some hepatitis C treatments, Harvoni can be taken without injections usually given to hepatitis C patients.
Innovative Therapies Inc. announced today the signing of a negative pressure wound therapy contract with the Mid-Atlantic Group Network of Shared Services, encompassing both rental and sales of ITI's proprietary NPWT technology.
› Verified 7 days ago
| Entity Name | Highland Hospital Of Rochester |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972548568 PECOS PAC ID: 5496641631 Enrollment ID: O20040225000444 |
News Archive
Prior Scientific's Z-Deck range is a high quality, height adjustable platform designed specifically for upright microscopes widely used in electrophysiology and neuroscience, including the Nikon FN1/Ni, the Olympus BX51WI / BX61WI, and the Zeiss Axio Examiner microscopes.
The Christian Science Monitor reports that the health overhaul is resting in the GOP's crosshairs. The ultimate defense to the repeal effort is the presidential veto pen. Even with a new majority in the House come January, Republicans concede that winning a repeal vote in the Democratic-controlled Senate is unlikely and the two-thirds needed to override a presidential veto, well out of reach.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that the U.S. Food and Drug Administration has approved the Company's Supplemental New Drug Application for FUSILEV Injection.
Insurers and patients are decrying the cost for the new drug, nearly $95,000 for a 12-week course of treatment, which is more expensive than Gilead's other hepatitis C drug, Sovaldi. But unlike some hepatitis C treatments, Harvoni can be taken without injections usually given to hepatitis C patients.
Innovative Therapies Inc. announced today the signing of a negative pressure wound therapy contract with the Mid-Atlantic Group Network of Shared Services, encompassing both rental and sales of ITI's proprietary NPWT technology.
› Verified 7 days ago
| Entity Name | Mary M Parkes Asthma & Pulmonary |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588610760 PECOS PAC ID: 9436126596 Enrollment ID: O20040916000932 |
News Archive
Prior Scientific's Z-Deck range is a high quality, height adjustable platform designed specifically for upright microscopes widely used in electrophysiology and neuroscience, including the Nikon FN1/Ni, the Olympus BX51WI / BX61WI, and the Zeiss Axio Examiner microscopes.
The Christian Science Monitor reports that the health overhaul is resting in the GOP's crosshairs. The ultimate defense to the repeal effort is the presidential veto pen. Even with a new majority in the House come January, Republicans concede that winning a repeal vote in the Democratic-controlled Senate is unlikely and the two-thirds needed to override a presidential veto, well out of reach.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that the U.S. Food and Drug Administration has approved the Company's Supplemental New Drug Application for FUSILEV Injection.
Insurers and patients are decrying the cost for the new drug, nearly $95,000 for a 12-week course of treatment, which is more expensive than Gilead's other hepatitis C drug, Sovaldi. But unlike some hepatitis C treatments, Harvoni can be taken without injections usually given to hepatitis C patients.
Innovative Therapies Inc. announced today the signing of a negative pressure wound therapy contract with the Mid-Atlantic Group Network of Shared Services, encompassing both rental and sales of ITI's proprietary NPWT technology.
› Verified 7 days ago
| Entity Name | Pulmonary Disease Clinical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881641652 PECOS PAC ID: 6608821657 Enrollment ID: O20050314000309 |
News Archive
Prior Scientific's Z-Deck range is a high quality, height adjustable platform designed specifically for upright microscopes widely used in electrophysiology and neuroscience, including the Nikon FN1/Ni, the Olympus BX51WI / BX61WI, and the Zeiss Axio Examiner microscopes.
The Christian Science Monitor reports that the health overhaul is resting in the GOP's crosshairs. The ultimate defense to the repeal effort is the presidential veto pen. Even with a new majority in the House come January, Republicans concede that winning a repeal vote in the Democratic-controlled Senate is unlikely and the two-thirds needed to override a presidential veto, well out of reach.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that the U.S. Food and Drug Administration has approved the Company's Supplemental New Drug Application for FUSILEV Injection.
Insurers and patients are decrying the cost for the new drug, nearly $95,000 for a 12-week course of treatment, which is more expensive than Gilead's other hepatitis C drug, Sovaldi. But unlike some hepatitis C treatments, Harvoni can be taken without injections usually given to hepatitis C patients.
Innovative Therapies Inc. announced today the signing of a negative pressure wound therapy contract with the Mid-Atlantic Group Network of Shared Services, encompassing both rental and sales of ITI's proprietary NPWT technology.
› Verified 7 days ago
| Entity Name | County Of Monroe |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265634067 PECOS PAC ID: 3072420959 Enrollment ID: O20071128000745 |
News Archive
Prior Scientific's Z-Deck range is a high quality, height adjustable platform designed specifically for upright microscopes widely used in electrophysiology and neuroscience, including the Nikon FN1/Ni, the Olympus BX51WI / BX61WI, and the Zeiss Axio Examiner microscopes.
The Christian Science Monitor reports that the health overhaul is resting in the GOP's crosshairs. The ultimate defense to the repeal effort is the presidential veto pen. Even with a new majority in the House come January, Republicans concede that winning a repeal vote in the Democratic-controlled Senate is unlikely and the two-thirds needed to override a presidential veto, well out of reach.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that the U.S. Food and Drug Administration has approved the Company's Supplemental New Drug Application for FUSILEV Injection.
Insurers and patients are decrying the cost for the new drug, nearly $95,000 for a 12-week course of treatment, which is more expensive than Gilead's other hepatitis C drug, Sovaldi. But unlike some hepatitis C treatments, Harvoni can be taken without injections usually given to hepatitis C patients.
Innovative Therapies Inc. announced today the signing of a negative pressure wound therapy contract with the Mid-Atlantic Group Network of Shared Services, encompassing both rental and sales of ITI's proprietary NPWT technology.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Irene Perillo, MD 601 Elmwood Ave, Box Med, Rochester, NY 14642-0001 Ph: (585) 275-4861 | Irene Perillo, MD 601 Elmwood Ave, Box Med, Rochester, NY 14642-0001 Ph: (585) 275-4861 |
News Archive
Prior Scientific's Z-Deck range is a high quality, height adjustable platform designed specifically for upright microscopes widely used in electrophysiology and neuroscience, including the Nikon FN1/Ni, the Olympus BX51WI / BX61WI, and the Zeiss Axio Examiner microscopes.
The Christian Science Monitor reports that the health overhaul is resting in the GOP's crosshairs. The ultimate defense to the repeal effort is the presidential veto pen. Even with a new majority in the House come January, Republicans concede that winning a repeal vote in the Democratic-controlled Senate is unlikely and the two-thirds needed to override a presidential veto, well out of reach.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that the U.S. Food and Drug Administration has approved the Company's Supplemental New Drug Application for FUSILEV Injection.
Insurers and patients are decrying the cost for the new drug, nearly $95,000 for a 12-week course of treatment, which is more expensive than Gilead's other hepatitis C drug, Sovaldi. But unlike some hepatitis C treatments, Harvoni can be taken without injections usually given to hepatitis C patients.
Innovative Therapies Inc. announced today the signing of a negative pressure wound therapy contract with the Mid-Atlantic Group Network of Shared Services, encompassing both rental and sales of ITI's proprietary NPWT technology.
› Verified 7 days ago
Amy Bodrog, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1425 Portland Ave, Rochester, NY 14621 Phone: 585-922-4020 Fax: 585-922-4622 | |
Natalia Golub, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 30 Hagen Dr Ste 320, Rochester, NY 14625 Phone: 585-922-1900 | |
Hanan Ibrahim Sheikh Ibrahim, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1415 Portland Ave Ste 200, Rochester, NY 14621 Phone: 585-922-0390 Fax: 585-922-0395 | |
Numra Aslam Bajwa, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1425 Portland Ave, Rochester, NY 14621 Phone: 585-922-5067 Fax: 716-862-1871 | |
Dr. Prakash Upreti, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1425 Portland Ave, Rochester, NY 14621 Phone: 295-029-8769 | |
William M Valenti, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 259 Monroe Avenue, Rochester, NY 14607 Phone: 585-545-7200 Fax: 585-244-6456 | |
Ms. Terri Winter, N.P. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 250 Crittenden Blvd, Box 617, Rochester, NY 14642 Phone: 585-275-2662 Fax: 585-276-0149 |